Clinical Trials Directory

Trials / Completed

CompletedNCT01663688

Data Collection Study of the Nidek Optical Coherence Tomography RS-3000 for 3D Measurements of the Eye

Normative Data Collection Study of the Nidek Optical Coherence Tomography RS-3000 for the Measurements of Retinal and RNFL Thickness and Optic Disc Analysis

Status
Completed
Phase
Study type
Observational
Enrollment
279 (actual)
Sponsor
Nidek Co. LTD. · Industry
Sex
All
Age
20 Years
Healthy volunteers
Accepted

Summary

The purpose of this clinical study is to collect and evaluate the data from eye scans using an investigational three-dimensional eye imaging photography device called the Nidek Optical Coherence Tomography (OCT) RS-3000. OCT stands for Optical Coherence Tomography, a technique that uses invisible wavelengths of light to make detailed images of the tissues at the back of the eye. These images provide information that physicians may use to help diagnose eye conditions and/or to monitor changes in the eye during treatment.

Detailed description

This is a prospective, open-labeled, multi-center clinical study. After qualifying examination of a subject, 3D retinal measurement in the proximity of the optic disc and the macula are carried out for eligible subjects with normal eyes using an investigational three-dimensional eye imaging photography device called the Nidek Optical Coherence Tomography (OCT) RS-3000. The primary objective of this clinical study is to develop age-specific normal ranges for the thickness of the retina and retinal nerve fiber layer (RNFL) etc. using the Nidek Optical Coherence Tomography (OCT) RS-3000 with normative database. The secondary objective is to evaluate any adverse events found during the clinical study.

Conditions

Timeline

Start date
2012-07-01
Primary completion
2013-06-01
Completion
2013-08-01
First posted
2012-08-13
Last updated
2014-01-20

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01663688. Inclusion in this directory is not an endorsement.